/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Alboukadel Kassambara

Modélisation et Ingénierie des Systèmes Complexes Biologiques pour le Diagnostic(FR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

80

Papers

7.7K

Citations

29

h-index

45

i10-index

Alboukadel Kassambara is an academic researcher from Modélisation et Ingénierie des Systèmes Complexes Biologiques pour le Diagnostic. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Histone Deacetylase Inhibitors Research. The author has an h-index of 29, co-authored 68 publications.

Research Topics

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Histone Deacetylase Inhibitors Research Data Analysis with R Immunotherapy and Immune Responses

Papers by this author

works

factoextra: Extract and Visualize the Results of Multivariate Data Analyses

2016 · 3,236 citations

https://doi.org/10.32614/cran.package.factoextra

Alboukadel Kassambara Fabian Mundt

1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma

2010 · EMBO Molecular Medicine · 41 citations

https://doi.org/10.1002/emmm.201000067

Alexandra Fournier Anne McLeer‐Florin Christine Lefebvre Samuel Duley

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells

2018 · British Journal of Cancer · 36 citations

https://doi.org/10.1038/s41416-018-0025-x

Angélique Bruyer Ken Maes Laurie Herviou Alboukadel Kassambara

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value

2016 · Biomarker Research · 18 citations

https://doi.org/10.1186/s40364-016-0057-4

Elena Viziteu Alboukadel Kassambara Philippe Pasero Bernard Klein

Additional file 4: of PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

2018 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.7164824

Laurie Herviou Alboukadel Kassambara StĂŠphanie Boireau Nicolas Robert

Additional file 8: of PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

2018 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.7164890

Laurie Herviou Alboukadel Kassambara StĂŠphanie Boireau Nicolas Robert

Research topics

topics

Multiple Myeloma Research and Treatments

Protein Degradation and Inhibitors

Histone Deacetylase Inhibitors Research

Data Analysis with R

Immunotherapy and Immune Responses

Chat about Author

Papers

Chat

Click to start Chat